DETECTION OF EGFR GENE MUTATIONS IN PATIENTS WITH ADVANCED NSCLC IN SLOVAK REPUBLIC

被引：0
|
作者：
Hlinkova, Katarina [1 ]
Piackova, Barbora [1 ]
Majer, Ivan [2 ]
Babal, Pavel [3 ]
Copakova, Lucia [1 ]
机构：
[1] Natl Canc Inst, Dept Canc Genet, Bratislava, Slovakia
[2] Comenius Univ, Fac Med, Dept Pneumol & Phtisiol, Bratislava 81806, Slovakia
[3] Comenius Univ, Fac Med, Dept Pathol, Bratislava 81806, Slovakia
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
EGFR mutations; HRMA; Direct sequencing; mutant-enriched PCR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S805 / S806
页数：2
相关论文
共 50 条
  • [41] Efficacy and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced NSCLC Harboring Sensitive EGFR Mutations
    Yamada, Y.
    Imai, H.
    Minemura, H.
    Sugiyama, T.
    Kaira, K.
    Kanazawa, K.
    Kasai, T.
    Minato, K.
    Kaburagi, T.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S943 - S943
  • [42] Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
    Chen, S.
    Zhao, J.
    Cui, L.
    Liu, Y.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (03): : 332 - 340
  • [43] Detection of EGFR Activating and Resistance Mutations by Droplet Digital PCR in Sputum of EGFR-Mutated NSCLC Patients
    Hackner, Klaus
    Buder, Anna
    Hochmair, Maximilian J.
    Strieder, Matthaeus
    Grech, Christina
    Fabikan, Hannah
    Burghuber, Otto C.
    Errhalt, Peter
    Filipits, Martin
    CLINICAL MEDICINE INSIGHTS-ONCOLOGY, 2021, 15
  • [44] Urinary circulating DNA detection for dynamic tracking of EGFR mutations for NSCLC patients treated with EGFR-TKIs
    S. Chen
    J. Zhao
    L. Cui
    Y. Liu
    Clinical and Translational Oncology, 2017, 19 : 332 - 340
  • [45] Rare and Common EGFR Mutations in Patients with Advanced NSCLC Treated with EGFR-TKIs: A Registry-Based Study
    Pesek, Milos
    Kolek, Vitezslav
    Skrickova, Jana
    Cernovska, Marketa
    Koubkova, Leona
    Roubec, Jaromir
    Salajka, Frantisek
    Zemanova, Milada
    Krejci, Jana
    Hejduk, Karel
    Ryska, Ales
    Minarik, Marek
    Fiala, Ondrej
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
  • [46] Results of testing for EGFR mutations in Mexican patients with NSCLC
    Ortiz-Ibarra, Javier
    Gonzalez-Zapata, Erika
    Valenzuela-Mendez, Ema
    GACETA MEXICANA DE ONCOLOGIA, 2013, 12 (06): : 401 - 404
  • [47] Clinical value of cfDNA and CTCs in EGFR mutations detected in advanced NSCLC
    Calabuig Farinas, S.
    Jantus-Lewintre, E.
    Fernandez, A.
    Mayo de las Casas, C.
    Blasco, A.
    Aguilar, C.
    Jordana, N.
    Balada, A.
    Garzon Ibanez, M.
    Zhang, F.
    Dong, N.
    Molina, M. A.
    Rosell, R.
    Camps Herrero, C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [48] Genetic Variations in the EGFR Gene Predicts Outcome in Advanced NSCLC Patients Treated with Erlotinib
    Larsen, Anne Winther
    Nissen, Peter H.
    Jakobsen, Kristine R.
    Demuth, Christina
    Sorensen, Boe S.
    Meldgaard, Peter
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S527 - S527
  • [49] Crizotinib in Advanced ALK-Positive NSCLC - A Retrospective Multicenter Study in the Slovak Republic
    Kasan, Peter
    Berzinec, Peter
    Plank, Lukas
    Andrasina, Igor
    Godal, Robert
    Mazal, Juraj
    Cipkova, Andrea
    Cerna, Maria
    Denkova, Lucia
    Chowaniecova, Gabriela
    Kuliskova, Iveta
    Kuzmova, Helena
    Martak, Marian
    Pribulova, Zuzana
    Reckova, Marian
    Vesela, Milada
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S529 - S529
  • [50] The association of mutations and increased copy number of the EGFR gene as predictors of erlotinib sensitivity in NSCLC patients
    Venesio, T.
    Casorzo, L.
    Balsamo, A.
    Corigliano, M.
    Garotte, L.
    Risio, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 39 - 39
12345